Product Information
RIZATRIPTAN 5 MG ODT is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.5150 per EA under NDC 57237008563. Its NADAC has been published 514 times since Oct 19, 2016.
FDA first approved this application on Jul 1, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237008563
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
RIZATRIPTAN BENZOATEApproval Type
Generic (ANDA)
FDA Application
ANDA203062FDA Approved
7/1/2013
TE Code
AB
On Market Since
7/1/2013
Pharmacological Classes
Price Statistics
The NADAC for RIZATRIPTAN 5 MG ODT has been published 514 times since Oct 19, 2016, and over the history we have for it it has declined 53.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5150 per EA |
|---|---|
| All-time high | $1.3658 (Dec 16, 2020) |
| All-time low | $0.4078 (Jul 17, 2024) |
| 52-week high | $0.5974 |
| 52-week low | $0.4842 |
| Median price | $0.8960 |
| Average price | $0.8641 |
| Largest weekly change | +69.8% (Aug 21, 2024) |
| Weeks tracked | 514 |
| Tracking since | Oct 19, 2016 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 38% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RIZATRIPTAN 5 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for RIZATRIPTAN 5 MG ODT, manufactured by Rising Pharma Holdings Inc., is $0.5150 per EA (NDC 57237008563), effective Aug 19, 2026.
How has the price of RIZATRIPTAN 5 MG ODT changed over time?
Over the history we have for it, the NADAC for RIZATRIPTAN 5 MG ODT has declined 53.1%. It has been tracked across 514 weekly CMS publications since Oct 19, 2016.
What are the highest and lowest recorded NADAC prices for RIZATRIPTAN 5 MG ODT?
Since Oct 19, 2016, the NADAC for RIZATRIPTAN 5 MG ODT has ranged from a low of $0.4078 (Jul 17, 2024) to a high of $1.3658 (Dec 16, 2020), with a median of $0.8960 per EA.
Are there cheaper alternatives to RIZATRIPTAN 5 MG ODT?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RIZATRIPTAN 5 MG TABLET, is $0.3203 per EA — about 38% below RIZATRIPTAN 5 MG ODT.
Who manufactures RIZATRIPTAN 5 MG ODT?
RIZATRIPTAN 5 MG ODT (NDC 57237008563) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.